A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations – results of a prematurely terminated study
Sign Up to like & getrecommendations! Published in 2018 at "Trials"
DOI: 10.1186/s13063-018-2702-8
Abstract: BackgroundStudies have suggested the reduced effectiveness of vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections with high vancomycin minimum inhibitory concentrations. Alternative agents such as daptomycin may be considered. We conducted a randomized controlled study… read more here.
Keywords: vancomycin; high vancomycin; minimum inhibitory; treatment ... See more keywords